Diabetes mellitus and risk of prostate cancer: A meta-analysis

Diabetologia

Volumn 47, Issue 6, 2004, Pages 1071-1078

  Bonovas, S ^a,b   Filioussi, K ^a   Tsantes, A ^a  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Diabetes mellitus; Epidemiology; Meta analysis; Prostatic neoplasms

Indexed keywords

CALCULATION; CANCER RISK; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EXPERIMENTAL DESIGN; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; META ANALYSIS; PEER REVIEW; PRIORITY JOURNAL; PROSTATE CANCER; PUBLICATION; RANDOMIZATION; REVIEW; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

EID: 3142729250     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1415-6     Document Type: Review

References (69)

1. Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273:1605-1609
2. Lagergren J, Bergstrom R, Nyren O (1999) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130:883-890
3. Strickler HD, Wylie-Rosett J, Rohan T et al. (2001) The relation of type 2 diabetes and cancer. Diabetes Technol Ther 3:263-274
4. La Vecchia C, Negri E, D'Avango B, Boyle P, Franceschi S (1990) Medical history and primary liver cancer. Cancer Res 50:6274-6277
5. Greenland S (1994) Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 140:290-296
6. Juni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282:1054-1060
7. Stroup DF, Berlin JA, Morton SC et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational studies in Epidemiology (MOOSE) Group. JAMA 283:2008-2012
8. Hasselblad V, Eddy DM, Kotchmar DJ (1992) Synthesis of environmental evidence. J Air Waste Manag Assoc 42: 662-671
9. Friedenreich CM, Brant RF, Riboli E (1994) Influence of methodologic factors in a pooled analysis of 13 case-control studies of colorectal cancer and dietary fiber. Epidemiology 5:66-67
10. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
11. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
12. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
13. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple graphical test. BMJ 315:629-634
14. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 8:101-129
15. Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15-17
16. Wilson EB, Maher HC (1932) Cancer and tuberculosis with some comments on cancer and other diseases. Am J Cancer 16:227-250
17. Glicksman AS, Rawson RW (1956) Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer 91:127-134
18. Bell ET (1957) Carcinoma of pancreas. I. Clinical and pathologic study of 600 necropsied cases. II. Relation of carcinoma of pancreas to diabetes mellitus. Am J Pathol 33:499-523
19. Lancaster HO, Maddox JK (1958) Diabetic mortality in Australia. Australas Ann Med 7:145-150
20. Steele JM, Sperling WL (1961) Relationship between diabetes mellitus and cancer: a study of the records for eight years at the Robert Packer Hospital. Guthr Clin Bull 30:63-67
21. Kessler II (1970) Cancer mortality among diabetics. J Natl Cancer Inst 44:673-686
22. Henderson BE, Bogdanoff E, Gerkins VR, SooHoo J, Arthur M (1974) Evaluation of cancer risk factors in a retirement community. Cancer Res 34:1045-1048
23. O'Mara BA, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 38:435-441
24. Adami HO, McLaughlin J, Ekbom A et al. (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307-314
25. Talamini R, Franceschi S, La Vecchia C, Serraino D, Barra S, Negri E (1992) Diet and prostatic cancer: a case-control study in northern Italy. Nutr Cancer 18:277-286
26. Hsieh CC, Thanos A, Mitropoulos D, Deliveliotis C, Mantzoros CS, Trichopoulos D (1999) Risk factors for prostate cancer: a case-control study in Greece. Int J Cancer 80:699-703
27. Rosenberg DJ, Neugut AI, Ahsan H, Shea S (2002) Diabetes mellitus and the risk of prostate cancer. Cancer Invest 20:157-165
28. Tavani A, Gallus S, Bosetti C et al. (2002) Diabetes and the risk of prostate cancer. Eur J Cancer Prev 11:125-128
29. Weiderpass E, Ye W, Vainio H, Kaaks R, Adami HO (2002) Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer 102:258-261
30. Will JC, Vinicor F, Calle EE (1999) Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology 10:313-318
31. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1998) Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 9:3-9
32. Wideroff L, Gridley G, Mellemkjaer L et al. (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360-1365
33. Coughlin SS, Neaton JD, Sengupta A (1996) Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol 143:1002-1006
34. Steenland K, Nowlin S, Palu S (1995) Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 4:807-811
35. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70:950-953
36. Smith GD, Egger M, Shipley MJ, Marmot MG (1992) Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol 136:1110-1114
37. Thompson MM, Garland C, Barrett-Connor E, Khaw KT, Friedlander NJ, Wingard DL (1989) Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol 129:511-517
38. Checkoway H, DiFerdinando G, Hulka BS, Mickey DD (1987) Medical, life-style, and occupational risk factors for prostate cancer. Prostate 10:79-88
39. Ragozzino M, Melton LJ 3rd, Chu CP, Palumbo PJ (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35:13-19
40. Wynder EL, Mabuchi K, Whitmore WF Jr (1971) Epidemiology of cancer of the prostate. Cancer 28:344-360
41. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR (1991) Publication bias in research. Lancet 337:867-872
42. Simes JR (1986) Publication bias: the case for an international registry of trials. J Clin Oncol 4:1529-1541
43. Sterling TD (1959) Publication decisions and their possible effects on inferences drawn from tests of significance - or vice versa. JASA 54:30-34
44. Nomura AMY, Kolonel LN (1991) Prostate cancer: a current perspective. Epidemiol Rev 13:200-227
45. Ries LA, Hankey BF, Edwards BK (1990) Cancer statistics review, 1973-1987. NIH Publication #90-2789. US GPO, Washington DC
46. Chodak GW, Schoenberg HW (1989) Progress and problems in screening for carcinoma of the prostate. World J Surg 13:60-64
47. Peehl DM, Stamey TA (1986) Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 22:82-90
48. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266-272
49. LeRoith D, Baserga R, Helman L, Roberts CT Jr (1995) Insulin-like growth factors and cancer. Ann Intern Med 122:54-59
50. Cohen P, Peehl DM, Graves HC, Rosenfeld RG (1994) Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 142:407-415
51. Cohen P, Peehl DM, Lamson G, Rosenfeld RG (1991) Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73:401-407
52. Iwamura M, Sluss PM, Casamento JB, Cockett AT (1993) Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate 22:243-252
53. Coffey DS (1979) Physiological control of prostatic growth: an overview. In: Prostate cancer. International Union Against Cancer. UICC Technical Report Series, vol 48, Geneva, pp 4-23
54. Hovenanian MS, Deming CL (1948) The heterologous growth of cancer of the human prostate. Surg Gynecol Obstet 86:29-35
55. Noble RL (1977) The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 37:1929-1933
56. Pollard M, Luckert PH, Schmidt MA (1982) Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone. Prostate 3:563-568
57. Robson MC (1966) Cirrhosis and prostatic neoplasms. Geriatrics 21:150-154
58. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ (1996) Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88:1118-1126
59. Ando S, Rubens R, Rottiers R (1984) Androgen plasma levels in male diabetics. J Endocrinol Invest 7:21-24
60. Barrett-Connor E, Khaw KT, Yen SS (1990) Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 132:895-901
61. Shahwan MM, Spathis GS, Fry DE, Wood PJ, Marks V (1978) Differences in pituitary and testicular function between diabetic patients on insulin and oral anti-diabetic agents. Diabetologia 15:13-17
62. Fushimi H, Horie H, Inoue T et al. (1989) Low testosterone levels in diabetic men and animals: a possible role in testicular impotence. Diabetes Res Clin Pract 6:297-301
63. Madsbad S, Gluud C, Bennett P, Krarup T (1986) Rapid changes in plasma androgens during insulin withdrawal in male type 1 (insulin-dependent) diabetics. J Endocrinol Invest 9:21-25
64. Small M, MacRury S, Beastall GH, MacCuish AC (1987) Oestradiol levels in diabetic men with and without a previous myocardial infarction. Q J Med 64:617-623
65. Barrett-Connor E (1992) Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med 117:807-811
66. Oksanen A (1975) Testicular lesions of streptozotocin diabetic rats. Horm Res 6:138-144
67. Hutson JC, Stocco DM, Campbell GT, Wagoner J (1983) Sertoli cell function in diabetic, insulin-treated diabetic, and semi-starved rats. Diabetes 32:112-116
68. Jackson FL, Hutson JC (1984) Altered responses to androgen in diabetic male rats. Diabetes 33:819-824
69. Murray FT, Orth J, Gunsalus G et al. (1981) The pituitary-testicular axis in the streptozotocin diabetic male rat: evidence for gonadotroph, Sertoli cell and Leydig cell dysfunction. Int J Androl 4:265-280